Janice Canvin

Omalizumab for the Treatment of Chronic Idiopathic or Spontaneous Urticaria

Marcus Maurer, Karin Rosén, Hsin-Ju Hsieh et al. · New England Journal of Medicine · 2013 · 1.1K citations · Full text

Life Sciences, Immunology, Pharmacotherapy +17

Omalizumab in patients with symptomatic chronic idiopathic/spontaneous urticaria despite standard combination therapy

Allen P. Kaplan, Dennis K. Ledford, Mark Ashby et al. · Journal of Allergy and Clinical Immunology · 2013 · 559 citations

Life Sciences, Immunology, Pharmacotherapy +11

Efficacy and Safety of Omalizumab in Patients with Chronic Idiopathic/Spontaneous Urticaria Who Remain Symptomatic on H1 Antihistamines: A Randomized, Placebo-Controlled Study

Sarbjit S. Saini, Carsten Bindslev‐Jensen, Marcus Maurer et al. · Journal of Investigative Dermatology · 2014 · 460 citations · Full text

Life Sciences, Pharmacology, Pharmacotherapy +11

Omalizumab and the risk of malignancy: Results from a pooled analysis

William W. Busse, Roland Buhl, Carlos Fernández Vidaurre et al. · Journal of Allergy and Clinical Immunology · 2012 · 172 citations

Medicine, Oncology, Pharmacotherapy +11

Randomized, double‐blind, placebo‐controlled glucosamine discontinuation trial in knee osteoarthritis

Jolanda Cibere, Jacek A. Kopec, Anona Thorne et al. · Arthritis Care & Research · 2004 · 141 citations

Medicine, Orthopaedic Surgery, Pharmacotherapy +13